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Introduction
Portugal has one of the highest MRSA infection and
colonization rates in Europe, so it becomes critical to
identify MRSA colonized patients at hospital admission
on the Emergency Room (ER), before placement into
wards, preventing the mixing of colonized patients with
non-colonized ones. Infection Control and Antibiotics
Committee (ICAC) developed an Electronic Epidemiolo-
gical Query at Admission (EEQA) to be answered at
patient admission. One of the questions targets MRSA
colonization risk.
Objectives
The objective of our study was to identify the positive
predictive value (PPV) of the question that targets the
MRSA high risk patient:Hospitalization or long term
care admission for at least 3 days in the last 3 months,
or tracheostomy?
Methods
With the approval of the Clinical Board, the ICAC defined
as mandatorily the fulfillment of EEQA to all patients at
admission. A positive answer to this question triggers
automatically (and without the doctors approval or intent)
nasal and perianal screening swabs for MRSA. Infection
Control nurse activates pre-emptive contact isolation pre-
cautions immediately. Swab results are known after 48h
and then precautions can be stopped or room isolation is
implemented.
Results
In 2014 we had 13.893 EEQA submitted; from these, 3.523
(23,36%) were positive for at least one of the 8 questions.
The question that targets MRSA colonized risk patient
had a positive answer in 3.082 EEQA (87,4% of the
positive EEQA, and 22,1% of all EEQA submitted). A PPV
value of 24,6%, with 759 cultural positive screening results
in 3.082 identified risk patient.
Conclusion
Using the EEQA, we’ve obtained a PPV of 24,6 % for the
question choosed to identify and screen colonized MRSA
risk patients. This value represents 759 MRSA patient
admissions in one year, who received adequate isolation
procedures, preventing their mixing with non MRSA
colonized patients during hospital stay. This may had a
decisive role on observed reduction of MRSA nosocomial
infection rate at our hospital.
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